Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-04-27
Original SEC Filing: Click here

---

Webplus: SVA/20180427/6-K/2_EX-99.1/000.htm SEC Original: tv492329_ex99-1.htm
Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing BEIJING, April 27, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it will delay the filing of its annual report on Form 20-F for

---

---

Webplus: SVA/20180427/6-K/1/000.htm SEC Original: tv492329_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-04-27CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085